Needham analyst Serge Belanger named Liquidia (LQDA) a top pick for 2025 with a Buy rating and $19 price target The stock was also the ...

Analyst Serge Belanger of Needham maintained a Buy rating on Liquidia Technologies (LQDA – Research Report), retaining the price target of ...

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

No link was found between Competitive Bidding Program implementation and changes in supplemental oxygen use or clinical ...

First Hawaiian Bank lessened its stake in shares of Johnson & Johnson (NYSE:JNJ – Free Report) by 0.8% during the fourth ...

In the ‘80s, researchers set out to test a medication called sildenafil citrate for treating high blood pressure and angina ...

Vitiligo, a skin condition causing depigmentation, may significantly increase the risk of serious cardiovascular events.

Smoke from wildfires — like the ones in Los Angeles — can have health consequences. Here's what experts expect.

While high blood pressure can contribute to renovascular disease, having renal (kidney) problems can also increase blood ...

According to JP Morgan, U.S. large-cap biopharma stocks have underperformed the broader market for two consecutive years, ...

The FDA approved a wide range of therapies in 2024, including many new molecular entities and biological products.